[go: up one dir, main page]

MX2024006292A - Anticuerpos monoclonales de adn dirigidos al virus de la influenza. - Google Patents

Anticuerpos monoclonales de adn dirigidos al virus de la influenza.

Info

Publication number
MX2024006292A
MX2024006292A MX2024006292A MX2024006292A MX2024006292A MX 2024006292 A MX2024006292 A MX 2024006292A MX 2024006292 A MX2024006292 A MX 2024006292A MX 2024006292 A MX2024006292 A MX 2024006292A MX 2024006292 A MX2024006292 A MX 2024006292A
Authority
MX
Mexico
Prior art keywords
monoclonal antibodies
influenza virus
antibodies targeting
targeting influenza
dna monoclonal
Prior art date
Application number
MX2024006292A
Other languages
English (en)
Inventor
David B Weiner
Jian Yan
Sarah Elliott
Ami Patel
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of MX2024006292A publication Critical patent/MX2024006292A/es

Links

Classifications

    • C07K16/108—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/248—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se describe en la presente una composición que incluye una secuencia de ácido nucleico recombinante que codifica un anticuerpo sintético anti-influenza-hemaglutinina; la descripción también proporciona un método para prevenir y/o tratar la influenza en un sujeto utilizando dicha composición y método de generación.
MX2024006292A 2016-05-05 2018-11-05 Anticuerpos monoclonales de adn dirigidos al virus de la influenza. MX2024006292A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662332381P 2016-05-05 2016-05-05
US201662376162P 2016-08-17 2016-08-17

Publications (1)

Publication Number Publication Date
MX2024006292A true MX2024006292A (es) 2024-08-26

Family

ID=60203613

Family Applications (8)

Application Number Title Priority Date Filing Date
MX2018013521A MX2018013521A (es) 2016-05-05 2017-05-05 Anticuerpos monoclonales de adn dirigidos al virus de la influenza.
MX2024006289A MX2024006289A (es) 2016-05-05 2018-11-05 Anticuerpos monoclonales de adn dirigidos al virus de la influenza.
MX2024000118A MX2024000118A (es) 2016-05-05 2018-11-05 Anticuerpos monoclonales de adn dirigidos al virus de la influenza.
MX2024006295A MX2024006295A (es) 2016-05-05 2018-11-05 Anticuerpos monoclonales de adn dirigidos al virus de la influenza.
MX2024006291A MX2024006291A (es) 2016-05-05 2018-11-05 Anticuerpos monoclonales de adn dirigidos al virus de la influenza.
MX2024006293A MX2024006293A (es) 2016-05-05 2018-11-05 Anticuerpos monoclonales de adn dirigidos al virus de la influenza.
MX2024006290A MX2024006290A (es) 2016-05-05 2018-11-05 Anticuerpos monoclonales de adn dirigidos al virus de la influenza.
MX2024006292A MX2024006292A (es) 2016-05-05 2018-11-05 Anticuerpos monoclonales de adn dirigidos al virus de la influenza.

Family Applications Before (7)

Application Number Title Priority Date Filing Date
MX2018013521A MX2018013521A (es) 2016-05-05 2017-05-05 Anticuerpos monoclonales de adn dirigidos al virus de la influenza.
MX2024006289A MX2024006289A (es) 2016-05-05 2018-11-05 Anticuerpos monoclonales de adn dirigidos al virus de la influenza.
MX2024000118A MX2024000118A (es) 2016-05-05 2018-11-05 Anticuerpos monoclonales de adn dirigidos al virus de la influenza.
MX2024006295A MX2024006295A (es) 2016-05-05 2018-11-05 Anticuerpos monoclonales de adn dirigidos al virus de la influenza.
MX2024006291A MX2024006291A (es) 2016-05-05 2018-11-05 Anticuerpos monoclonales de adn dirigidos al virus de la influenza.
MX2024006293A MX2024006293A (es) 2016-05-05 2018-11-05 Anticuerpos monoclonales de adn dirigidos al virus de la influenza.
MX2024006290A MX2024006290A (es) 2016-05-05 2018-11-05 Anticuerpos monoclonales de adn dirigidos al virus de la influenza.

Country Status (11)

Country Link
US (2) US11851477B2 (es)
EP (1) EP3452504A4 (es)
JP (3) JP7506869B2 (es)
KR (4) KR102375324B1 (es)
CN (2) CN110325546B (es)
AU (2) AU2017261305B2 (es)
BR (1) BR112018072708A2 (es)
CA (1) CA3023093A1 (es)
MX (8) MX2018013521A (es)
SG (2) SG10202011021XA (es)
WO (1) WO2017192946A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110325546B (zh) * 2016-05-05 2024-03-19 宾夕法尼亚大学理事会 靶向流感病毒的dna单克隆抗体
JP2020500033A (ja) * 2016-11-07 2020-01-09 ザ ウィスター インスティテュート オブ アナトミー アンド バイオロジー ライム病に対する使用のためのｄｎａ抗体構築物
AU2020323601A1 (en) * 2019-07-31 2022-03-03 The Wistar Institute Of Anatomy And Biology Multivalent DNA antibody constructs and use thereof
EP4027982A1 (en) * 2019-09-11 2022-07-20 ModernaTX, Inc. Lnp-formulated mrna therapeutics and use thereof for treating human subjects
IL312538A (en) * 2021-11-05 2024-07-01 Abviro Llc Broadly reactive human monoclonal influenza antibodies and methods for their use
WO2025226722A1 (en) * 2024-04-22 2025-10-30 The Wistar Institute Of Anatomy And Biology Dna antibody and immunogen constructs for use in methods of treating and preventing influenza

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040087521A1 (en) * 1993-03-18 2004-05-06 Merck & Co., Inc. Nucleic acid pharmaceuticals-influenza matrix
CN100494370C (zh) * 2006-05-26 2009-06-03 神州细胞工程有限公司 一种优化的单克隆抗体
CN101541832B (zh) * 2006-09-07 2014-11-12 克鲁塞尔荷兰公司 能中和流感病毒h5n1的人结合分子及其应用
CN102264896B (zh) * 2008-12-25 2014-02-26 国立大学法人大阪大学 抗人流感病毒人型抗体
WO2011041391A1 (en) * 2009-09-29 2011-04-07 Fraunhofer Usa, Inc. Influenza hemagglutinin antibodies, compositions, and related methods
US9587010B2 (en) * 2011-07-18 2017-03-07 The Institute For Research In Biomedicine Neutralizing anti-influenza A virus antibodies and uses thereof
WO2013114885A1 (en) * 2012-01-31 2013-08-08 Osaka University Human monoclonal antibodies broadly protective against influenza b virus and methods of using the same
MX2015007575A (es) * 2012-12-13 2016-03-15 Univ Pennsylvania Construcciones de anticuerpos de adn y metodo para utilizarlas.
SG11201604719WA (en) 2013-12-13 2016-07-28 Univ Pennsylvania Dna antibody constructs and method of using same
MX2017007187A (es) * 2014-12-01 2018-01-30 Univ Pennsylvania Construcciones de anticuerpos de adn y metodo para utilizarlas.
US20190091322A1 (en) * 2016-03-21 2019-03-28 David B. Weiner Dna antibody constructs and method of using same
CN110325546B (zh) * 2016-05-05 2024-03-19 宾夕法尼亚大学理事会 靶向流感病毒的dna单克隆抗体

Also Published As

Publication number Publication date
MX2024006291A (es) 2024-08-26
MX2024000118A (es) 2024-01-22
KR20240155978A (ko) 2024-10-29
AU2017261305A8 (en) 2019-08-08
CN110325546B (zh) 2024-03-19
CA3023093A1 (en) 2017-11-09
US11851477B2 (en) 2023-12-26
MX2024006290A (es) 2024-08-26
MX2024006295A (es) 2024-08-26
JP2025081330A (ja) 2025-05-27
KR20220035288A (ko) 2022-03-21
CN118109478A (zh) 2024-05-31
JP2022116034A (ja) 2022-08-09
WO2017192946A8 (en) 2018-12-27
MX2024006289A (es) 2024-08-26
KR102375324B1 (ko) 2022-03-18
SG10202011021XA (en) 2020-12-30
WO2017192946A1 (en) 2017-11-09
AU2017261305A1 (en) 2018-12-20
AU2024203297A1 (en) 2024-06-13
KR20190035614A (ko) 2019-04-03
BR112018072708A2 (pt) 2019-02-19
US20240150442A1 (en) 2024-05-09
JP2019521702A (ja) 2019-08-08
AU2017261305B2 (en) 2024-06-13
SG11201809783RA (en) 2018-12-28
JP7506869B2 (ja) 2024-06-27
MX2018013521A (es) 2019-06-10
EP3452504A1 (en) 2019-03-13
KR20230125851A (ko) 2023-08-29
CN110325546A (zh) 2019-10-11
MX2024006293A (es) 2024-08-26
EP3452504A4 (en) 2020-07-29
US20190135899A1 (en) 2019-05-09

Similar Documents

Publication Publication Date Title
MX2024006289A (es) Anticuerpos monoclonales de adn dirigidos al virus de la influenza.
MX2024010988A (es) Anticuerpos monoclonales de adn dirigidos a moleculas de punto de control.
ZA202311412B (en) Anti-phf-tau antibodies and uses thereof
JOP20200091A1 (ar) جسم مضاد يبطل فعالية فيروس الالتهاب الرئوي البشري
PH12019500540A1 (en) Anti-pd-1 antibodies and their uses
PH12019501357A1 (en) Anti-ox40 antibodies and their uses
BR112017011326A2 (pt) anticorpo, ácido nucleico, vetor, célula hospedeira, método para produzir o anticorpo, imunoconjugado, composição farmacêutica, usos do anticorpo, métodos para tratar ou retardar a progressão de distúrbio proliferativo celular e para intensificar a função imune
MX2023009421A (es) Construcciones de anticuerpos de adn y metodo para utilizarlas.
BR112017009728A2 (pt) anticorpos isolados, ácido nucleico isolado, vetor, célula hospedeira, método para produzir o anticorpo, composição, usos de um anticorpo e métodos de tratamento de um distúrbio
MX420844B (es) Receptores de antígenos quiméricos dirigidos a bcma y métodos de uso de estos.
MX2021011167A (es) Anticuerpos humanizados anti grupo de diferenciacion 19 (cd19) humano y metodos de uso.
PH12021550521A1 (en) Antibodies that potently neutralize rabies virus and other lyssaviruses and uses thereof
PH12019502298A1 (en) Monoclonal antibody to pd-l1
MX2020003806A (es) Anticuerpos monoclonales de adn que se dirigen a ctla-4 para el tratamiento y prevención del cáncer.
MX2019007924A (es) Vacunas contra la influenza.
MX2025009846A (es) Composiciones que comprenden moleculas de acido nucleico que codifican anticuerpos sinteticos anti-il-6 y anti-cd126
WO2019139648A3 (en) Dna antibody constructs for use against ebola virus
WO2019075300A3 (en) Mayaro virus consensus antigens, dna antibody constructs for use against mayaro virus, and combinations thereof
EA201892124A1 (ru) Днк-конструкции антител и способы их применения
EA201892523A1 (ru) Днк-моноклональные антитела, нацеленные на вирус гриппа